STOCK TITAN

Bunge Global SA Financials

BG
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Bunge Global SA (BG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BG FY2025

Thin-margin throughput defined FY2025: a much larger balance sheet supported more sales, but incremental volume produced little added profit.

From FY2024 to FY2025, revenue jumped from $53.1B to $70.3B, yet gross profit barely moved, which means the company processed far more business without keeping more value per dollar; top-line size alone says little about profitability here. At the same time, inventory-heavy working capital and higher borrowing pushed assets to $44.5B while operating cash flow fell to $844M, a sign that scale required funding rather than releasing cash.

Cash conversion was not stable across the last three years: free cash flow swung from $2.2B in FY2023 to -$879M in FY2025 as capital spending and working-capital needs rose together. That makes reported earnings less informative on their own, because cash generation depends heavily on how much inventory and trade credit the business must carry.

The balance sheet still shows a usable liquidity cushion, but it is not a cash-rich one; FY2025 ended with $1.1B of cash against $8.8B of long-term debt. In practice, that means day-to-day flexibility relies more on turning inventories and receivables into cash than on sitting on a large reserve.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 32 / 100
Financial Health Score 32/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Bunge Global SA's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
62

Bunge Global SA's revenue surged 32.4% year-over-year to $70.3B, reflecting rapid business expansion. This strong growth earns a score of 62/100.

Leverage
58

Bunge Global SA has a moderate D/E ratio of 0.56. This balance of debt and equity financing earns a leverage score of 58/100.

Liquidity
45

Bunge Global SA's current ratio of 1.61 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
29

While Bunge Global SA generated $844.0M in operating cash flow, capex of $1.7B consumed most of it, leaving -$879.0M in free cash flow. This results in a low score of 29/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Partial
3/8

Bunge Global SA passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.03x

For every $1 of reported earnings, Bunge Global SA generates $1.03 in operating cash flow ($844.0M OCF vs $816.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$70.3B
YoY+32.4%

Bunge Global SA generated $70.3B in revenue in fiscal year 2025. This represents an increase of 32.4% from the prior year.

EBITDA
N/A
Net Income
$816.0M
YoY-28.2%

Bunge Global SA reported $816.0M in net income in fiscal year 2025. This represents a decrease of 28.2% from the prior year.

EPS (Diluted)
$4.91
YoY-38.5%

Bunge Global SA earned $4.91 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 38.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$879.0M
YoY-267.7%

Bunge Global SA generated -$879.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 267.7% from the prior year.

Cash & Debt
$1.1B
YoY-65.7%

Bunge Global SA held $1.1B in cash against $8.8B in long-term debt as of fiscal year 2025.

Dividends Per Share
$2.80
YoY+2.9%

Bunge Global SA paid $2.80 per share in dividends in fiscal year 2025. This represents an increase of 2.9% from the prior year.

Shares Outstanding
N/A

Margins & Returns

Gross Margin
4.9%
YoY-1.5pp

Bunge Global SA's gross margin was 4.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the prior year.

Operating Margin
N/A
Net Margin
1.2%
YoY-1.0pp

Bunge Global SA's net profit margin was 1.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.0 percentage points from the prior year.

Return on Equity
5.1%
YoY-6.3pp

Bunge Global SA's ROE was 5.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.3 percentage points from the prior year.

Capital Allocation

R&D Spending
$28.0M
YoY-6.7%

Bunge Global SA invested $28.0M in research and development in fiscal year 2025. This represents a decrease of 6.7% from the prior year.

Share Buybacks
$551.0M
YoY-49.9%

Bunge Global SA spent $551.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 49.9% from the prior year.

Capital Expenditures
$1.7B
YoY+25.2%

Bunge Global SA invested $1.7B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 25.2% from the prior year.

BG Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $21.9B-8.0% $23.8B+7.3% $22.2B+73.5% $12.8B+9.7% $11.6B-14.0% $13.5B+4.9% $12.9B-2.5% $13.2B
Cost of Revenue $21.1B N/A $21.1B+75.3% $12.0B+8.9% $11.0B N/A $12.1B-3.5% $12.6B
Gross Profit $766.0M-24.2% $1.0B-4.9% $1.1B+44.0% $738.0M+23.6% $597.0M-44.8% $1.1B+40.0% $772.0M+16.3% $664.0M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $531.0M N/A $678.0M+62.2% $418.0M+10.0% $380.0M N/A $437.0M-2.7% $449.0M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $181.0M N/A $202.0M+90.6% $106.0M+1.9% $104.0M N/A $127.0M+3.3% $123.0M
Income Tax -$14.0M N/A $86.0M-30.6% $124.0M+55.0% $80.0M N/A $89.0M+196.7% $30.0M
Net Income $68.0M-28.4% $95.0M-42.8% $166.0M-53.1% $354.0M+76.1% $201.0M-66.6% $602.0M+172.4% $221.0M+215.7% $70.0M
EPS (Diluted) $0.35-28.6% $0.49-41.7% $0.84-67.8% $2.61+76.4% $1.48-66.1% $4.36+179.5% $1.56+225.0% $0.48

BG Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $47.6B+6.8% $44.5B-3.8% $46.3B+48.6% $31.2B+16.9% $26.7B+7.1% $24.9B-1.5% $25.3B+3.4% $24.4B
Current Assets $27.1B+11.1% $24.4B-8.7% $26.7B+24.6% $21.4B+23.4% $17.4B+8.9% $16.0B+0.2% $15.9B+3.0% $15.5B
Cash & Equivalents $839.0M-26.1% $1.1B-13.7% $1.3B-80.6% $6.8B+109.2% $3.2B-2.0% $3.3B+16.7% $2.8B+144.3% $1.2B
Inventory $15.4B+16.9% $13.2B-0.9% $13.3B+66.1% $8.0B+2.5% $7.8B+20.4% $6.5B-13.0% $7.5B-7.3% $8.1B
Accounts Receivable $4.0B+2.7% $3.9B+10.8% $3.5B+54.7% $2.3B-3.3% $2.3B+8.7% $2.1B+2.3% $2.1B-7.8% $2.3B
Goodwill $3.3B+4.8% $3.1B+13.4% $2.8B+502.0% $460.0M-0.6% $463.0M+2.2% $453.0M-6.0% $482.0M+3.4% $466.0M
Total Liabilities $31.5B+10.2% $28.6B-6.2% $30.5B+50.6% $20.3B+26.0% $16.1B+7.3% $15.0B-1.0% $15.1B+4.9% $14.4B
Current Liabilities $16.9B+12.0% $15.1B-6.0% $16.1B+55.0% $10.4B+21.7% $8.5B+14.8% $7.4B-3.3% $7.7B+1.1% $7.6B
Long-Term Debt $9.9B+12.6% $8.8B-10.0% $9.8B+39.3% $7.0B+49.4% $4.7B+0.4% $4.7B-1.7% $4.8B+16.9% $4.1B
Total Equity $16.0B+0.9% $15.9B+0.9% $15.8B+44.9% $10.9B+2.9% $10.6B+6.7% $9.9B-2.2% $10.1B+1.3% $10.0B
Retained Earnings $13.2B+0.5% $13.2B+0.8% $13.1B+0.3% $13.0B-0.2% $13.0B+1.5% $12.8B+5.0% $12.2B+1.9% $12.0B

BG Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$541.0M-140.2% $1.3B+57.7% $854.0M+179.7% -$1.1B-276.1% -$285.0M-127.1% $1.1B-20.6% $1.3B+190.0% -$1.5B
Capital Expenditures $336.0M-37.5% $538.0M+14.7% $469.0M+15.5% $406.0M+31.0% $310.0M-36.6% $489.0M+38.1% $354.0M+19.2% $297.0M
Free Cash Flow -$877.0M-208.4% $809.0M+110.1% $385.0M+126.0% -$1.5B-148.4% -$595.0M-205.5% $564.0M-42.0% $973.0M+154.9% -$1.8B
Investing Cash Flow -$182.0M-161.3% $297.0M+105.5% -$5.4B-3146.1% $178.0M+163.6% -$280.0M-78.3% -$157.0M+61.6% -$409.0M-169.1% -$152.0M
Financing Cash Flow $406.0M+122.7% -$1.8B-95.4% -$917.0M-120.6% $4.4B+807.8% $490.0M+205.2% -$466.0M-161.0% $764.0M+692.2% -$129.0M
Dividends Paid $136.0M+0.7% $135.0M-2.9% $139.0M+47.9% $94.0M+3.3% $91.0M0.0% $91.0M-5.2% $96.0M0.0% $96.0M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

BG Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 3.5%-0.8pp 4.3%-0.5pp 4.8%-1.0pp 5.8%+0.6pp 5.1%-2.8pp 8.0%+2.0pp 6.0%+1.0pp 5.0%
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 0.3%-0.1pp 0.4%-0.3pp 0.8%-2.0pp 2.8%+1.0pp 1.7%-2.7pp 4.5%+2.7pp 1.7%+1.2pp 0.5%
Return on Equity 0.4%-0.2pp 0.6%-0.5pp 1.1%-2.2pp 3.3%+1.4pp 1.9%-4.2pp 6.1%+3.9pp 2.2%+1.5pp 0.7%
Return on Assets 0.1%-0.1pp 0.2%-0.1pp 0.4%-0.8pp 1.1%+0.4pp 0.8%-1.7pp 2.4%+1.6pp 0.9%+0.6pp 0.3%
Current Ratio 1.60-0.0 1.61-0.0 1.66-0.4 2.07+0.0 2.04-0.1 2.15+0.1 2.07+0.0 2.03
Debt-to-Equity 0.62+0.1 0.56-0.1 0.62-0.0 0.65+0.2 0.45-0.0 0.470.0 0.47+0.1 0.41
FCF Margin -4.0%-7.4pp 3.4%+1.7pp 1.7%+13.3pp -11.6%-6.5pp -5.1%-9.3pp 4.2%-3.4pp 7.5%+20.9pp -13.4%

Similar Companies

Frequently Asked Questions

Bunge Global SA (BG) reported $70.3B in total revenue for fiscal year 2025. This represents a 32.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Bunge Global SA (BG) revenue grew by 32.4% year-over-year, from $53.1B to $70.3B in fiscal year 2025.

Yes, Bunge Global SA (BG) reported a net income of $816.0M in fiscal year 2025, with a net profit margin of 1.2%.

Bunge Global SA (BG) reported diluted earnings per share of $4.91 for fiscal year 2025. This represents a -38.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Bunge Global SA (BG) had $1.1B in cash and equivalents against $8.8B in long-term debt.

Bunge Global SA (BG) had a gross margin of 4.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Bunge Global SA (BG) had a net profit margin of 1.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Bunge Global SA (BG) paid $2.80 per share in dividends during fiscal year 2025.

Bunge Global SA (BG) has a return on equity of 5.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Bunge Global SA (BG) generated -$879.0M in free cash flow during fiscal year 2025. This represents a -267.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Bunge Global SA (BG) generated $844.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Bunge Global SA (BG) had $44.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Bunge Global SA (BG) invested $1.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Bunge Global SA (BG) invested $28.0M in research and development during fiscal year 2025.

Yes, Bunge Global SA (BG) spent $551.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Bunge Global SA (BG) had a current ratio of 1.61 as of fiscal year 2025, which is generally considered healthy.

Bunge Global SA (BG) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Bunge Global SA (BG) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Bunge Global SA (BG) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Bunge Global SA (BG) has an earnings quality ratio of 1.03x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Bunge Global SA (BG) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top